A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Oral HRS-5041 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 20, 2025

Primary Completion Date

August 1, 2025

Study Completion Date

August 1, 2025

Conditions

Prostate Cancer

Interventions

DRUG

HRS-5041 Tablets

HRS-5041 tablets.

DRUG

Rifampicin Capsule

Rifampicin capsule.

Trial Locations (1)

The First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital), Jinan

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY